Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Short Interest Update

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) was the target of a significant growth in short interest in the month of February. As of February 28th, there was short interest totalling 406,500 shares, a growth of 202.2% from the February 13th total of 134,500 shares. Currently, 2.0% of the shares of the company are sold short. Based on an average daily volume of 469,300 shares, the short-interest ratio is currently 0.9 days.

Analyst Ratings Changes

Separately, KeyCorp began coverage on shares of Rapid Micro Biosystems in a research report on Wednesday, February 12th. They set an “overweight” rating and a $8.00 price target for the company.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of RPID. Millennium Management LLC grew its holdings in shares of Rapid Micro Biosystems by 17.6% during the fourth quarter. Millennium Management LLC now owns 61,375 shares of the company’s stock worth $55,000 after buying an additional 9,191 shares in the last quarter. Citadel Advisors LLC acquired a new position in Rapid Micro Biosystems during the fourth quarter worth about $65,000. Finally, Renaissance Technologies LLC boosted its position in Rapid Micro Biosystems by 122.9% during the fourth quarter. Renaissance Technologies LLC now owns 183,087 shares of the company’s stock worth $165,000 after acquiring an additional 100,942 shares during the last quarter. 52.60% of the stock is owned by hedge funds and other institutional investors.

Rapid Micro Biosystems Trading Up 6.2 %

Shares of NASDAQ:RPID opened at $2.39 on Thursday. Rapid Micro Biosystems has a 12-month low of $0.58 and a 12-month high of $4.04. The business has a 50 day moving average of $2.20 and a two-hundred day moving average of $1.39. The company has a market capitalization of $103.34 million, a PE ratio of -2.13 and a beta of 1.08.

Rapid Micro Biosystems (NASDAQ:RPID) last posted its earnings results on Friday, February 28th. The company reported ($0.22) EPS for the quarter, meeting analysts’ consensus estimates of ($0.22). The firm had revenue of $8.22 million for the quarter, compared to analysts’ expectations of $8.20 million. Rapid Micro Biosystems had a negative return on equity of 48.05% and a negative net margin of 184.93%. Equities research analysts predict that Rapid Micro Biosystems will post -1.1 earnings per share for the current fiscal year.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.